[HTML][HTML] The kinetics of mRNA transforming growth factor beta1 expression and its serum concentration in graft-versus-host disease after allogeneic hemopoietic stem …
S Kyrcz-Krzemień, G Helbig, P Zielińska… - … medical journal of …, 2011 - ncbi.nlm.nih.gov
S Kyrcz-Krzemień, G Helbig, P Zielińska, M Markiewicz
Medical science monitor: international medical journal of experimental …, 2011•ncbi.nlm.nih.govThe kinetics of mRNA transforming growth factor beta1 expression and its serum concentration
in graft-versus-host disease after allogeneic hemopoietic stem cell transplantation for myeloid
leukemias - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI
Homepage MyNCBI Homepage Main Content Main Navigation Search PMC Full-Text Archive
Search in PMC Advanced Search User Guide Journal List Med Sci Monit v.17(6); 2011
PMC3539544 Other Formats PubReader PDF (221K) Actions Cite Collections Share Permalink …
in graft-versus-host disease after allogeneic hemopoietic stem cell transplantation for myeloid
leukemias - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI
Homepage MyNCBI Homepage Main Content Main Navigation Search PMC Full-Text Archive
Search in PMC Advanced Search User Guide Journal List Med Sci Monit v.17(6); 2011
PMC3539544 Other Formats PubReader PDF (221K) Actions Cite Collections Share Permalink …
Summary
Background
Graft-versus-host disease (GVHD) is still a major complication following allogeneic hematopoietic stem cell transplantation (alloHSCT). Recent data indicates that transforming growth factor beta1 (TGF-β1) may play a role in development of GVH reaction.
ncbi.nlm.nih.gov